# Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury

> **NCT00654680** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 418 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Vardenafil (Levitra, BAY38-9456)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00654680
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** 418 (ACTUAL)
- **Last updated:** 2013-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654680, "Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00654680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*